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The case is reported of a patient with pulmonary and ocular tuberculosis presenting with blurred vision
in both eyes. A 27-year-old well-nourished male nursing-home resident with a previous history of
traumatic intracerebral hemorrhage was brought to the ophthalmological clinic due to progressively
blurred vision. His best-corrected visual acuity was 20/400 in the right eye with only light perception in
the left eye. Fundus examinations revealed retinal segmental periphlebitis and hemorrhagic retinitis in
the right eye and dense vitreous hemorrhage in the left eye. The Mantoux test was negative; however,
the results of an interferon gamma release assay were positive. Ocular tuberculosis was suspected.
Although he had never had any respiratory symptoms, his chest radiograph and computed tomography
scan showed a multiple centrilobular glandular and ground-glass appearance with air-space consoli-
dations and atelectasis in both lower lobes. Pulmonary tuberculosis was conﬁrmed by a positive acid-fast
stain of a bronchial alveolar lavage sample. A GEN-PROBE ampliﬁed Mycobacterium tuberculosis direct
test of the vitreous ﬂuids was also positive. Ocular tuberculosis was conﬁrmed. After treatment for
tuberculosis and vitrectomies, his ﬁnal best-corrected visual acuity improved to 20/30 in the right eye
and 20/200 in the left eye. Ocular tuberculosis is rarely reported as the primary presentation of systemic
tuberculosis in young patients. A negative Mantoux test may lead to misdiagnosis and delayed treatment.
Doctors should become more familiar with the manifestations of systemic tuberculosis and use advanced
diagnostic tools in cases of clinical suspicion.
Copyright © 2014, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Tuberculosis (TB) usually infects the lungs and is a slowly pro-
gressive, chronic, necrotizing or nonnecrotizing, and granuloma-
tous or nongranulomatous infection caused by Mycobacterium
tuberculosis (MTB). Alveolar macrophages acquire phagocytic and
bactericidal functions and may limit the pulmonary infection.
However, some organisms may escape through the lymphatic or
blood systems or hematogenously, resulting in seeding of the or-
ganisms in other organs, including the cardiovascular system, theancial conﬂicts of interest in
not have any commercial or
ogy, China Medical University
n.
ciety of Taiwan. Published by Elsegastrointestinal system, the musculoskeletal system, the genito-
urinary tract, the central nervous system, the skin, and the eyes.1,2
In regions with a naturally high immunity to MTB, reactivation of
the latent infection may occur. In developing countries where a
high ratio of TB infection and low natural resistance exist, the risk of
inhaling bacilli on several occasions is high and may cause
reinfection. Ocular TB can be acquired by direct infection or by an
indirect immune-mediated hypersensitivity response to mycobac-
terial antigens; it is a great mimicker of various uveitis entities.3,4
The Mantoux test (a tuberculin puriﬁed protein derivative test) is
a screening tool for TB and is one of the major tuberculin skin tests
used around the world.
We report the case of a patient with deﬁnite pulmonary plus
ocular tuberculosis who had a negative Mantoux test result. We
also review the currently available laboratory methods for the
conﬁrmation of tuberculosis.vier Taiwan LLC. All rights reserved.
Fig. 2. Fluorescein angiography results showing occlusive retinal phlebitis with late
leakage.
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The patient presented here was a 27-year-old well-nourished
male nursing-home resident with a previous history of traumatic
intracerebral hemorrhage. He was mentally and physically
disabled. He was brought to the ophthalmological clinic of the local
hospital as a result of progressively blurred vision in both eyes for 2
weeks. Based on our impression of branch retinal vein occlusion in
the right eye and vitreous hemorrhage in the left eye, an intravitreal
bevacizumab injection and laser photocoagualtionwere performed
in the right eye; however, a vitreous hemorrhage was seen to have
developed at the 6-month follow up. He was therefore referred to a
tertiary care center for further evaluation and management.
On examination, his best-corrected visual acuity was 20/400 in
the right eye with only light perception in the left eye. The intra-
ocular pressure was within the normal range. Slit-lamp examina-
tion showed broad-based posterior synechiae in the left eye, which
obscured the details of the fundus. Reviewing the presenting
fundus photographs revealed retinal segmental phlebitis with
perivenous clustering and hemorrhagic retinitis (Fig.1). Fluorescein
angiography revealed occlusive retinal phlebitis with late leakage
(Fig. 2). A B-scan examination showed vitreous hemorrhage in his
left eye.
The results of his blood investigations, including a complete
blood count, random blood sugar, and routine serum biochemistry,
were within normal limits. The results for the lupus anticoagulant,
anticardiolipin antibody, rapid plasma regain, and HIV Ag/Ab
combo tests were negative. A culture of the anterior chamber ﬂuid
showed no growth. The Mantoux test was negative, but an inter-
feron gamma release assay (IGRA) was positive. Ocular TB was
therefore suspected.
Although the patient had no respiratory problems, his chest
radiograph revealed amultiple centrilobular glandular and ground-
glass appearance in both lungs (Fig. 3). A chest computed tomog-
raphy scan showed air-space consolidations and atelectasis in both
lower lobes (Fig. 4). Deﬁnite pulmonary TB was conﬁrmed due to
the positive acid-fast stain from bronchial alveolar lavage by
bronchoscope. Drugs for treating TB, including ethambutol, pyr-
azinamide, rifamycin, and isoniazid, were prescribed.
The vitreous hemorrhage and tractional retinal detachment
worsened in both eyes. Small gauge vitrectomies, membraneFig. 1. Fundus photographs showing retinal segmental phlebitis with perivenous
clustering and hemorrhagic retinitis.peeling, and endolaser photocoagulation were performed. Deﬁnite
ocular TB was conﬁrmed by the positive results of the GEN-PROBE
ampliﬁed MTB complex (MTBC) direct test of the vitreous humor
approximately 1 year after the onset of symptoms. After treatment
for TB and surgery, his ﬁnal best-corrected visual acuity improved
to 20/30 in the right eye and 20/200 in the left eye.3. Discussion
TB is a slowly progressive chronic infection caused by MTB. It
mainly affects the lungs, but can also affect other organs and sys-
tems, including ocular tissue.1,2 Ocular TB can be acquired by direct
infection or via an indirect immune-mediated hypersensitivity
response to MTB antigens. It is a great mimicker of various kinds of
uveitis.3,4 MTB can thrive in the retinal pigment epithelium (RPE),
which is similar to the alveolar macrophage environment in which
the bacteria normally develop and grow.5 RPE may serve as a
sanctuary for MTB. Reactivation of dormant organisms in the RPE orFig. 3. Chest radiograph of our patient showing a multiple centrilobular glandular and
ground-glass appearance in both lungs.
Fig. 4. Chest computed tomography scan of our patient showing air-space consoli-
dations and atelectasis in both lower lobes.
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microorganisms may cause ocular TB.6
The clinical manifestations of ocular TB include necrotizing
and nonnecrotizing diffuse or nodular scleritis, episcleritis, pe-
ripheral ulcerative keratitis, interstitial keratitis, phlyctenulosis,
dacryoadenitis, granulomatous or nongranulomatous acute ante-
rior uveitis, broad-based posterior synechiae, iris nodules, ciliary
body tuberculoma, granulomatous or nongranulomatous interme-
diate uveitis, posterior uveitis, panuveitis, neuroretinitis, and optic
neuropathy.3,4,6 The characteristics of posterior uveitis include
choroidal tubercle, subretinal abscess, serpiginous-like posterior
pole involvement, and periphlebitis of the retinal vessels with the
accumulation of a whitish material around the retinal veins.7e9 The
affected retinal vessels may have pigment along them or RPE
depigmentation under previous periphlebitis. Hemorrhagic reti-
nitis and focal choroiditis are usually located adjacent to the
affected retinal veins.10
Fluorescein angiography is an essential component of the
evaluation and management of presumed tuberculous retinal
vasculitis. Tuberculous retinal vasculitis is typically an obliterative
periphlebitis, which may cause nonperfusion of a substantial
portion of the retina. It may lead to proliferative vascular retinop-
athy. In acute vasculitis, ﬂuorescein angiography may reveal diffuse
leakage of dye and staining of the blood vessels. Cystoid macular
edema and optic disc leakage have sometimes been noted. Our
patient had the characteristic of retinal segmental phlebitis and
diffuse late phase vascular leakage on ﬂuorescein angiography.
The diagnosis of ocular TB was difﬁcult due to the inability to
demonstrate acid-fast bacilli on a smear sample or histopathology
in the ocular specimens. The paucity of available ocular tissue was
another issue. Molecular diagnostic techniques such as polymerase
chain reaction (PCR) results from the aqueous or vitreous humor
have low sensitivities due to the low bacterial load in the ocular
ﬂuids and the thick cell wall of MTB.11,12 For this reason, most
previous diagnoses of ocular TB have been presumptive, based on
the ocular signs consistent with TB, evidence of systemic TB, and a
positive Mantoux test.The Mantoux test is one of the few investigations dating from
the 19th century that is still widely used as an important test for
diagnosing TB.13 A positive Mantoux test result indicates myco-
bacterial infection with or without manifest clinical disease. How-
ever, the Bacillus CalmetteeGuerin (BCG) vaccination may induce
false-positive results. In Taiwan, the BCG vaccination has been
given routinely at birth since 1965 and is repeated in elementary
school if the Mantoux test result is negative. According to the data
provided by a recent national survey in Taiwan, the BCG vaccination
rate is 97% among ﬁrst-grade students.
False-negative reactions, which are estimated to occur in
approximately 5e10% of patients, can be observed early in the
infection before hypersensitivity develops, in anergic individuals, in
those with severe illness (including active TB), in newborn infants
and in infants <3 months of age, and as a result of improper
techniques in handling the puriﬁed protein derivative solution,
administering the intradermal injection, and interpreting the re-
sults.14 The Mantoux test may also show false-negative results in
immunosuppressed patients. Nevertheless, the Mantoux test still
has an important role in high-risk groups, such as immigrants from
regions where TB is endemic.
In the general population in the USA, the sensitivity of the
Mantoux test is 0.59e1.0, with a speciﬁcity of 0.95e1.0, and a
positive predictive value of 0.44e1.0.15 In a recent study enrolling
immunocompetent Asian adults aged from 20 to 29 years old, the
Mantoux test was shown to be sufﬁciently accurate in differenti-
ating active TB from other diseases, with a high sensitivity of up to
94% and a speciﬁcity up to 88%, although there were still some
patients who had an unexplained negative Mantoux test while
presenting with active TB symptoms. From our experience of the
patient reported here, a belief in the relatively high sensitivity of
the Mantoux test might hinder an accurate diagnosis. Therefore, an
adjuvant test such as IGRA is still important in initiating early
treatment in highly suspicious clinical situations. This will guar-
antee the continuous application of such an inexpensive, simple,
and widely applied tool, especially in the community and in
resource-limited settings.16
The change in the Mantoux test result from positive to negative
is called “reversion”. This reversion has been reported for decades,
but most commonly in the context of isoniazid preventive treat-
ment among healthy mycobacterium contacts. The reported
reversion rates vary widely and differences in study design, study
populations, and the ability to control for potential confounders,
such as the timing of the initial conversion, repeated exposure to
mycobacterium, chronic nontuberculous mycobacterium exposure,
and receipt of the BCG vaccine, have made it difﬁcult to draw
conclusions with respect to the frequency and biological signiﬁ-
cance of reversion. A recent study showed aMantoux test reversion
of approximately 20% (25 patients from 122 patients with positive
Mantoux test results) after isoniazid preventive treatment.17 An
earlier large series of a healthy African population in an area with
endemic TB had a reversion rate from 1.39 to 3.72 per 100 patient-
years.18 All these studies involved patients at high risk of TB
infection, but without active TB infection. Although some studies
included patients in whom the Mantoux test result had reversed
after treatment, some studies involved patients in whom the
Mantoux test result reversed spontaneously. Thus reversion is
possible and may involve multiple factors other than preventive
treatment. The patients in these studies with reversion were those
who had a milder initial reaction. Based on these results, the pos-
sibility of Mantoux test reversion in our patient was very small
because it is difﬁcult to explain the disappearance of the immune
response during disease progression without any evidence of
compromise of the immune system or malnutrition. On the con-
trary, active TB with an initially negative Mantoux test result has
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Mantoux test during disease progression after increasing the dose
of tuberculin or repeated testing.19
The duration of Mantoux test reversion also varied among
different studies, ranging from months to years.17,18 However, all
these studies involved participants at high risk of TB, not patients
with active TB infection before treatment. When doctors have a
patient with clinically suspected TB infection and a positive
Mantoux test result, they do not need to perform the test twice
before treatment. Data concerning the duration of Mantoux test
reversion in active TB infection before treatment is therefore
sparse.
Real-time PCR assays have been used successfully for the
detection of the MTB complex in clinical samples.10e12 An overall
sensitivity of 86.3% and 100% speciﬁcity in detecting MTB has been
reported previously.11 The low sensitivity is due to the low bacterial
load in the ocular ﬂuid and the thick cell wall of the MTB. The
sensitivity of the PCR assay could be improved by using different
primers and probes, such as primers targeting the MPB64 gene of
MTB.12
The GEN-PROBE ampliﬁed MTB direct test was the ﬁrst nucleic
acid ampliﬁcation test to obtain US Food and Drug Administration
approval in 1996 for the detection of pulmonary TB, followed by the
Roche Amplicor MTB Test in 2009.20 The target RNA is the 16S rRNA
of the MTBC. The GEN-PROBE ampliﬁed MTBC direct test had
higher sensitivity than microscopy (83% vs. 50%), but a similar
speciﬁcity (95% vs. 96%).21 Unlike microscopy, the sensitivity of the
GEN-PROBE ampliﬁed MTBC direct test was not signiﬁcantly lower
in patients with HIV coinfection.22 However, the performance of
this MTBC detection test in a nonpulmonary sample has not been
validated with a 5-mL or larger sample. A positive result indicates
infection with either both the nontuberculosis mycobacterium and
MTB, or MTB alone.
The T-cell IGRA assay (Cellestis Inc., Chadstone, Victoria,
Australia) provides a measurement of the interferon gamma pro-
duced by T cells in response to stimulation by relatively speciﬁc
MTB antigens (ESAT-6, CFP-10, TB7.7).23,24 The advantages of this
assay include prompt, same-day results and a greater speciﬁcity for
the MTB antigen with a decreased response to nontuberculous
mycobacterial antigens (e.g., Mycobacterium avium-intracellulare).
The more mycobacteria that are present, the higher the sensitiza-
tion, resulting in a higher response in the whole blood test.
Extremely high quantiferon levels (mean 7.49 U/mL) were reported
in patients with tuberculous uveitis.25 Active typical ocular
inﬂammation and a positive IGRA result, with or without other
systemic signs, are considered as possible TB-associated uveitis.
Given that IGRAs enable differentiation between vaccinated and
truly infected patients, IGRA is recommended as the ﬁrst test to be
performed in preference to T-SPOT.TB (Oxford Immunotech,
Abingdon, Oxfordshire, UK) and the Mantoux test for the diagnosis
of tuberculous uveitis.26
The guidelines for the diagnosis of ocular TB are as follows: (1)
exclusion of other uveitis entities; (2) clinical history and signs
consistent with ocular TB; (3) direct evidence from ocular in-
vestigations (such as positive acid-fast bacilli smear, MTB culture of
ocular specimen, or ocular ﬂuid PCR for MTB) so that a deﬁnite
diagnosis can be made; (4) systemic investigations (including a
positive Mantoux test, IGRA, or a healed or active tubercular lesion
on a chest radiograph) are corroborative evidence and a presumed
diagnosis can be made; (5) conﬁrmed active extrapulmonary TB
with microscopic examination or culture of the affected tissue for
MTB; and (6) a therapeutic test with a positive response to four-
drug treatment for TB over 4e6 weeks.4,6,12,24e26
Our patient was young andwell-nourished and should therefore
have been in an immunocompetent state at the time ofpresentation. Although the culture of the anterior chamber ﬂuid
showed no growth and the Mantoux test result was negative, his
IGRA result was positive. In addition to the bilateral active tuber-
cular lesion in the lungs evidenced by the chest radiograph and
computed tomography scan, deﬁnite pulmonary TB was also
consolidated by a positive acid-fast stain of the bronchial alveolar
lavage sample obtained by bronchoscope. In severe cases of ocular
TB, vitreous hemorrhage and tractional retinal detachment may
develop. Prompt vitreoretinal surgery with coverage by systemic
drug treatment is mandatory in these patients. Ocular TB was
therefore initially suspected in this patient and was later conﬁrmed
by the positive MTBC direct test on the vitreous sample. His best-
corrected visual acuity improved from 20/400 to 20/30 in the
right eye and his light perception in the left eye improved to 20/
1000 after treatment.
It is insufﬁcient to conﬁrm the diagnosis of ocular TB by a pos-
itive Mantoux test result and chest radiograph alone. Wroblewski
et al27 reported that only 10 patients out of 17 patients with a
positive histopathology had a positive Mantoux test result. In
addition, 14 sets of chest radiographic results were submitted and
8/14 (57%) patients had normal chest radiographic results. Both of
these ﬁndings highlight the unclear reliability of the routine
Mantoux test and chest radiographs in ocular TB. The T-cell IGRA
may be an alternative choice in helping to diagnose ocular TB. It
providesmeasurement of the interferon gamma produced by Tcells
in response to stimulation by relatively speciﬁc MTB antigens. The
advantages of the IGRA over the Mantoux test include prompt,
same-day results and a greater speciﬁcity for the MTB antigen,
given its decreased response to nontuberculous mycobacterial an-
tigens (e.g., M. avium-intracellulare).17 In our patient, the Mantoux
test was false-negative, but the IGRA test was positive.
The treatment of ocular tuberculosis includes ﬁrst-line four-
drug treatment for TB and subsequent treatment with steroids.
Regular follow up and close monitoring for the development of
retinal neovascularization, subsequent vitreous hemorrhage, and
tractional retinal detachment are very important. Timely laser
treatment and vitrectomy aremandatory. Ocular TB infection is rare
in an immunocompetent patient, which may, unfortunately, lead to
misdiagnosis and delayed treatment. Ophthalmologists should
therefore be familiar with the possible manifestations of this
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